Managing interventional clinical trials in the setting of COVID-19: Experience in an autoimmune skin disease unit

Robert Borucki; Josef Symon S Concha; Julie Burroughs; Joyce Okawa; Victoria P Werth

doi:10.1016/j.jdin.2020.11.002

Managing interventional clinical trials in the setting of COVID-19: Experience in an autoimmune skin disease unit

JAAD Int. 2021 Mar:2:94-95. doi: 10.1016/j.jdin.2020.11.002. Epub 2020 Dec 9.

Authors

Robert Borucki¹, Josef Symon S Concha¹, Julie Burroughs¹, Joyce Okawa¹, Victoria P Werth¹

Affiliation

¹ Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania and Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.

No abstract available

Keywords: COVID-19; IMP, investigational medicinal product; clinical trials; cutaneous lupus erythematosus; dermatomyositis; novel therapies; teledermatology.

Publication types

Editorial

Grants and funding

R01 AR071653/AR/NIAMS NIH HHS/United States